Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

Share Price is delayed by 15 minutes
Get Live Data
289.60    0.00 (0.00%)
Bid:
290.60
Ask:
291.00
Spread: 0.40 (0.138%)
Market Cap: £3.23b
EMG Live PriceLast checked at - London Stock Exchange

Intraday Man Share Chart

Directorate Change

19 Oct 2022 07:00

RNS Number : 3210D
Man Group plc
19 October 2022
 

Directorate Change

19 October 2022

Man Group plc (the "Company") announces the appointment of Alberto Musalem as a non-executive director of the Company and as a member of the Audit & Risk Committee and Remuneration Committee with effect from 1 November 2022.

John Cryan, Chair of Man Group, said:  "I am delighted to welcome Alberto to the Man Group Board. He brings extensive investment management experience, economic and public policy expertise and broad knowledge of capital markets and regulation. I am confident that Alberto will add significant value to Man Group and we look forward to working with him."

Alberto Musalem - previous experience

Alberto served as CEO and Co-CIO of Evince Asset Management LP (2018 - 2022), an investment manager which he co-founded. Prior to this, he served as Executive Vice President and Senior Advisor to the President at the Federal Reserve Bank of New York (2014 - 2017) where he led the Integrated Policy Analysis and the Emerging Markets and International Affairs Groups, and served on the Bank's Management Committee. Alberto held senior positions at Tudor Investment Corporation (2000 - 2013), including Managing Director, Partner, Global Head of Research, and member of the firm's Management Committee. He also served as an economist at the International Monetary Fund (1996 - 2000). 

Alberto is currently a director of Freddie Mac, a US federal home loan mortgage corporation founded by Congress, where he is a member of the Risk Committee, Operations and Technology Committee and Compensation and Human Capital Committee. He is a member of the Distinguished Advisory Group of the Integrity Council for the Voluntary Carbon Market, the Council on Foreign Relations, and the Economic Club of New York. He is also Adjunct Professor of Finance at Georgetown University's McDonough School of Business.

This announcement is made in compliance with the Company's obligations under Listing Rule 9.6.11R.

The Company confirms that no other disclosures are required pursuant to Listing Rule 9.6.13R.

 

Enquiries

Man Group

Communications

Georgiana Brunner

+44 20 7144 1000

media@man.com

 

Investor Relations

Karan Shirgaokar

+44 20 7144 1434

investor.relations@man.com

 

Company Secretary

Elizabeth Woods

+44 20 7144 1733

company.secretarial@man.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWONRUNURAAA
Date   Source Headline
23rd Jan 20235:50 pmRNSTransaction in Own Shares
23rd Jan 20237:00 amRNSTotal Voting Rights
20th Jan 20235:43 pmRNSTransaction in Own Shares
19th Jan 20235:52 pmRNSTransaction in Own Shares
18th Jan 20236:00 pmRNSTransaction in Own Shares
17th Jan 20235:49 pmRNSTransaction in Own Shares
16th Jan 20236:18 pmRNSTransaction in Own Shares
13th Jan 20235:51 pmRNSTransaction in Own Shares
12th Jan 20235:43 pmRNSTransaction in Own Shares
11th Jan 20235:49 pmRNSTransaction in Own Shares
10th Jan 20235:50 pmRNSTransaction in Own Shares
9th Jan 20235:46 pmRNSTransaction in Own Shares
6th Jan 20236:10 pmRNSHolding(s) in Company
6th Jan 20235:51 pmRNSTransaction in Own Shares
5th Jan 20235:55 pmRNSTransaction in Own Shares
4th Jan 20235:55 pmRNSTransaction in Own Shares
3rd Jan 20235:45 pmRNSTransaction in Own Shares
3rd Jan 20237:00 amRNSTotal Voting Rights
22nd Dec 20225:51 pmRNSTransaction in Own Shares
21st Dec 20226:04 pmRNSTransaction in Own Shares
20th Dec 20225:33 pmRNSTransaction in Own Shares
19th Dec 20226:05 pmRNSTransaction in Own Shares
19th Dec 20222:00 pmRNSDirector/PDMR Shareholding
16th Dec 20225:48 pmRNSTransaction in Own Shares
16th Dec 20222:00 pmRNSDirector Declaration
15th Dec 20226:02 pmRNSTransaction in Own Shares
14th Dec 20225:37 pmRNSTransaction in Own Shares
14th Dec 20223:00 pmRNSDirector/PDMR Shareholding
13th Dec 20225:43 pmRNSTransaction in Own Shares
12th Dec 20225:57 pmRNSTransaction in Own Shares
12th Dec 20223:15 pmRNSDirector/PDMR Shareholding
12th Dec 202212:45 pmRNSHolding(s) in Company
9th Dec 20225:53 pmRNSTransaction in Own Shares
9th Dec 20222:00 pmRNSDirector Declaration
9th Dec 20227:00 amRNSShare buyback programme of up to $125 million
9th Dec 20227:00 amRNSTreasury Share Cancellation & Total Voting Rights
1st Dec 20227:00 amRNSTotal Voting Rights
30th Nov 20225:30 pmRNSHolding(s) in Company
24th Nov 202212:45 pmRNSHolding(s) in Company
1st Nov 20227:00 amRNSTotal Voting Rights
19th Oct 20227:00 amRNSDirectorate Change
19th Oct 20227:00 amRNSTrading statement - Q3 2022
18th Oct 202211:30 amRNSHolding(s) in Company
11th Oct 20224:15 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSTotal Voting Rights
14th Sep 20224:45 pmRNSDirector/PDMR Shareholding
13th Sep 20225:39 pmRNSTransaction in Own Shares
12th Sep 20225:45 pmRNSTransaction in Own Shares
9th Sep 20225:40 pmRNSTransaction in Own Shares
9th Sep 20224:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.